Clinical bottom line
Perioperative neurocognitive disorders (PND), including postoperative delirium and longer-term cognitive decline, remain a significant concern in elderly surgical patients. Emerging evidence supports the use of multimodal neuroprotective anesthetic strategies tailored to reduce neuroinflammation and surgical stress, potentially mitigating PND incidence and severity. Regional anesthesia techniques, such as modified deep serratus anterior plane blocks, may also contribute to improved neurocognitive outcomes by attenuating surgical stress responses. However, patient-specific risk factors, including preexisting cognitive impairment and systemic inflammation, strongly influence PND risk and should guide perioperative management. Current data are hypothesis-generating and warrant further validation in larger, diverse cohorts before widespread protocol adoption.
What the evidence shows
Recent systematic review data (Rai et al., 2026) highlight that multimodal neuroprotective anesthetic approaches—combining pharmacologic agents with regional anesthesia and optimized intraoperative management—can reduce the incidence of PND in geriatric patients. These strategies aim to minimize neuroinflammation, oxidative stress, and anesthetic neurotoxicity, which are implicated in PND pathogenesis.
Li et al. (2021) identified key risk factors for PND in elderly patients undergoing surgery for gastrointestinal tumors, including advanced age, baseline cognitive impairment, and elevated inflammatory markers. Their findings emphasize the importance of preoperative risk stratification to tailor anesthetic plans.
Cheng et al. (2024) demonstrated in a randomized clinical study that modified deep serratus anterior plane block reduced surgical stress markers and was associated with lower rates of PND in elderly thoracic surgery patients. This suggests regional anesthesia techniques may confer neuroprotective benefits beyond analgesia.
Thedim et al. (2025) reviewed anesthetic sensitivity and resilience in the aging brain, underscoring that age-related changes in neurobiology influence vulnerability to anesthetic agents and perioperative insults. This work supports personalized anesthetic dosing and monitoring to mitigate cognitive risks.
Koh et al. (2025) discussed the role of cytokines in PND, highlighting that perioperative neuroinflammation is a key mechanistic driver. Targeting inflammatory pathways perioperatively may represent a promising therapeutic avenue.
Ibinson et al. (2019) reviewed neuroimaging modalities for PND, which may aid in early diagnosis and mechanistic understanding but are not yet standard clinical tools.
Caveats and uncertainty
Despite promising findings, the evidence base remains limited by heterogeneous study designs, small sample sizes, and variable definitions of PND. Most studies focus on short-term cognitive outcomes; long-term effects are less well characterized. The interplay between anesthetic agents, surgical stress, and individual patient factors is complex, and causality remains difficult to establish.
Multimodal neuroprotective strategies vary widely in components and implementation, complicating direct comparisons and generalizability. The efficacy of regional anesthesia for neuroprotection requires confirmation in larger, multicenter trials.
Biomarkers and neuroimaging for PND risk stratification and diagnosis are still investigational and not routinely available in clinical practice. The role of systemic inflammation and cytokines, while biologically plausible, lacks definitive interventional evidence.
Finally, the aging brain’s variable anesthetic sensitivity necessitates individualized approaches, but standardized protocols for dose adjustment or monitoring are not yet established.
How this may change practice
Clinicians should maintain heightened awareness of PND risk in elderly surgical patients and incorporate comprehensive preoperative cognitive assessments and inflammatory marker evaluation when feasible. Employing multimodal neuroprotective anesthetic strategies—such as combining regional anesthesia with judicious use of neuroprotective agents—may reduce PND incidence, particularly in high-risk populations.
Regional anesthesia techniques like the modified deep serratus anterior plane block may be considered as part of an integrated approach to minimize surgical stress and neurocognitive complications.
Perioperative teams should monitor emerging evidence on biomarkers and neuroimaging to refine risk stratification and early detection of PND.
Ultimately, anesthetic management should be individualized, balancing neuroprotection with surgical and patient-specific factors. Further research is needed to establish standardized protocols and validate interventions before routine clinical implementation.